The 22Rv1 tumor-bearing mice in the nonblocking group showed rapid tumor targeting 30 min after injection of the PSMA-Cy5 probe through the tail vein, and the TBR reached its highest value at 60 min. This evidence concerns the gene FOLH1 and neoplasm.